This special collection is a brief commentary on the latest research on prostate cancer and benign prostatic hyperplasia diagnosis, staging and treatment featuring articles published in Prostate Cancer and Prostatic Diseases (PCAN). The articles were selected by Prof. Cosimo De Nunzio, Editor-in-Chief.

This special collection entitled “Prostate biopsy: evolving strategies and perspectives” gathers a selection of recent articles published in Prostate Cancer and Prostatic Diseases (PCAN), focusing on relevant and debated aspects in the field of prostate biopsy. The featured papers address timely and clinically significant topics, ranging from the role of multiparametric MRI in guiding biopsy decisions and omission strategies, to the influence of prostate volume and core number on cancer detection. Furthermore, the ongoing transition—and debate—from transrectal to transperineal approaches is well explored. Together, these contributions offer a comprehensive and up-to-date overview of current evidence, controversies, and future directions in prostate biopsy, providing valuable insights for clinicians and experts in the field.

This special collection entitled “New trends on the management of localized prostate cancer” features articles recently published in Prostate Cancer and Prostatic Diseases (PCAN) covering some relevant and controversial topics in the context of diagnosis, staging and treatment of localized prostate cancer. The collection was performed in collaboration between editors of PCAN and members of the scientific committee of the Italian Society of Urology. The collection features recent papers by some of the top researchers in the field and will highlight some topics of particular interest for our readers: - comparison between techniques to guide prostate biopsy - role of PSMA PET/CT in the staging of prostate cancer - urinary continence after robot-assisted radical prostatectomy - sexual outcome after radical prostatectomy in MSM - single-port prostatic surgery - management of radio-recurrent prostate cancer

This special collection is a brief commentary on the latest research on prostate cancer and benign prostatic hyperplasia diagnosis, staging and treatment featuring articles published in Prostate Cancer and Prostatic Diseases (PCAN) in 2024. Articles were selected by Prof. Cosimo De Nunzio, Editor in Chief of PCAN.

Prostate cancer screening was revolutionized in the early 1990s with the wide spread availability and FDA approval of PSA testing. PSA however is not specific for clinically significant prostate cancer and while PSA testing improves prostate cancer specific mortality worries regarding how wide-spread screening could lead to overdiagnosis and overtreatment emerged. Currently prostate cancer screening is not equated with PSA screening. Rather there is a tiered approach ideally utilizing more specific biomarkers and imaging prior to initial biopsy. Moreover, personalized screening strategies which may include genetics, family history and baseline biomarkers are emerging. This collection covers recent updates and advances in prostate cancer screening and diagnosis.

The Editor of Prostate Cancer and Prostatic Diseases is delighted to share with you this Editor's Choice collection featuring some of the best research and reviews published in the journal in 2023. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers.

This special collection entitled “The times have changed. Let the urologists change!” features articles recently accepted and published in Prostate Cancer and Prostatic Diseases (PCAN) covering the new and exciting field of the minimally invasive surgical techniques for benign prostatic hyperplasia and lower urinary tract symptoms. Both PCAN Editors , Cosimo De Nunzio and Luca Cindolo, already considered experts in the BPH/LUTS diagnosis and treatment, created this dedicated collection. The collection features recent papers by some of the top investigators within the field and particularly will highlight three topics of particular interest for our readers: - LUTS/BPH pathophysiology - New Ablative technique to manage LUTS/BPH - MIST and ejaculatory function

The Emerging Leaders collection welcomes and recognizes new talent in the oncology field. This collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers. It serves as a platform to showcase Emerging Leaders and their exciting work in the prostate cancer and prostatic diseases field.

The Editors of Prostate Cancer and Prostatic Diseases (PCAN) are proud to present a special collection on “Disparities in Prostate Cancer Diagnosis and Management”. The collection features papers from recent years by some of the top investigators within the field, highlighting recognized disparities in prostate cancer care, from screening to risk stratification and treatments employed in patient care pathways. This special collection will highlight three topics of particular interest: (1) Disparities in prostate cancer prognosis (2) Differences in genomic profiling interpretation (3) Variable use of biomarkers and imaging

This special collection features articles published in Prostate Cancer and Prostatic Diseases (PCAN) in recent years relating to the link between obesity and dietary factors with prostate cancer.

The Editor of Prostate Cancer and Prostatic Diseases is delighted to share with you this Editor's Choice collection featuring some of the best research and reviews published in the journal in 2022. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers.

This special collection features articles published in Prostate Cancer and Prostatic Diseases (PCAN) in recent years relating to the link between physical activity and prostate cancer.